SA PRO
Free Account
Sutro Biopharma, Inc.STRONASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Mar 14, 2025Piper Sandler
Sutro Biopharma downgraded to Neutral from Overweight at Piper Sandler
Target:$2.00
+146.9%from $0.81
Oct 11, 2024Bank of America Securities
BofA Securities Reiterates Buy Rating on Sutro Biopharma (STRO)
Target:$12.00
+232.9%from $3.60
Oct 11, 2024H.C. Wainwright
H.C. Wainwright Reiterates Buy Rating on Sutro Biopharma (STRO)
Target:$12.00
+232.4%from $3.61
Aug 16, 2024Truist Financial
Sutro Biopharma (STRO) PT Lowered to $15 at Truist Securities
Target:$15.00
+256.3%from $4.21
May 14, 2024Deutsche Bank
Sutro Biopharma (STRO) PT Lowered to $10 at Deutsche Bank
Target:$10.00
+130.4%from $4.34
May 14, 2024Wedbush
Wedbush Reiterates Outperform Rating on Sutro Biopharma (STRO)
Target:$8.00
+89.1%from $4.23
Apr 3, 2024Oppenheimer
Oppenheimer Reiterates Outperform Rating on Sutro Biopharma (STRO)
Target:$10.00
+96.5%from $5.09
Apr 3, 2024Piper Sandler
Sutro Biopharma (STRO) PT Lowered to $11 at Piper Sandler
Target:$11.00
+116.1%from $5.09
Apr 2, 2024Truist Financial
Sutro Biopharma (STRO) PT Lowered to $18 at Truist Securities
Target:$18.00
+253.6%from $5.09
Jan 13, 2023Truist Financial
Truist Securities Maintains Buy on Sutro Biopharma, Raises Price Target to $25
Target:$25.00
+207.3%from $8.13
Jan 10, 2023Piper Sandler
Piper Sandler Maintains Overweight on Sutro Biopharma, Raises Price Target to $18
Target:$18.00
+117.1%from $8.29
Jun 28, 2022Piper Sandler
Sutro Biopharma price target raised to $16 from $14 at Piper Sandler
Target:$16.00
+216.8%from $5.05

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance